Eric Francis Yves Thepaut Boston Scientific Corp (BSX) insider trading activity

Eric Francis Yves Thepaut is EVP & Pres, Eur, Mid-East, Afr of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 31,421 shares of BSX, which is worth approximately $2.8 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 12,931 shares (Common Stock) at a price of $74.14 per share, resulting in proceeds of $958,704. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.4K

0% 3M change

156.12% 12M change

Total Value Held $2.8 Million

Eric Francis Yves Thepaut Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 10 2024	SELL Open market or private sale	$958,704 $74.14 p/Share	12,931 Reduced 29.16%	31,421 Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	$210,904 $16.31 p/Share	12,931 Added 22.57%	44,352 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$76,351 $65.82 p/Share	1,160 Reduced 3.72%	30,043 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	2,002 Added 6.03%	31,203 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$95,307 $65.82 p/Share	1,448 Reduced 4.72%	29,201 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	2,500 Added 7.54%	30,649 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$86,290 $65.82 p/Share	1,311 Reduced 4.45%	28,149 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	2,263 Added 7.13%	29,460 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$90,879 $65.95 p/Share	1,378 Reduced 4.82%	27,197 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,379 Added 7.69%	28,575 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	11,579 Reduced 30.65%	26,196 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	20,000 Added 34.62%	37,775 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$437,795 $57.81 p/Share	7,573 Reduced 29.88%	17,775 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	13,080 Added 34.04%	25,348 Common Stock
May 02 2023	SELL Open market or private sale	$4,377,718 $52.49 p/Share	83,401 Reduced 87.18%	12,268 Common Stock
May 02 2023	BUY Exercise of conversion of derivative security	$395,568 $12.89 p/Share	30,688 Added 24.29%	95,669 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$45,906 $46.23 p/Share	993 Reduced 1.51%	64,981 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	1,714 Added 2.53%	65,974 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$53,939 $46.54 p/Share	1,159 Reduced 1.77%	64,260 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	2,001 Added 2.97%	65,419 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$67,389 $46.54 p/Share	1,448 Reduced 2.23%	63,418 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	2,500 Added 3.71%	64,866 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$60,888 $46.48 p/Share	1,310 Reduced 2.06%	62,366 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	2,262 Added 3.43%	63,676 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$50,553 $47.29 p/Share	1,069 Reduced 1.71%	61,414 Common Stock

EFY

Eric Francis Yves Thepaut

EVP & Pres, Eur, Mid-East, Afr

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account